Multidrug resistance protein-mediated transport of chlorambucil and melphalan conjugated to glutathione
1998

Transport of Chlorambucil and Melphalan by MRP1

publication Evidence: moderate

Author Information

Author(s): K Barnouin, I Leier, G Jedlitschky, A Pourtier-Manzanedo, J Konig, W-D Lehmann, D Keppler

Primary Institution: Deutsches Krebsforschungszentrum

Hypothesis

The study investigates the ATP-dependent transport of glutathione S-conjugates of chlorambucil and melphalan by the multidrug resistance protein MRP1.

Conclusion

The study found that glutathione conjugation is necessary for the export of chlorambucil and melphalan from cells, and MRP1-mediated transport may not be the rate-limiting step in chlorambucil resistance.

Supporting Evidence

  • MRP1 is an ATP-dependent export pump for glutathione S-conjugates.
  • Monoglutathionyl chlorambucil was transported at higher rates than other conjugates.
  • Native chlorambucil was not a substrate for MRP1 transport.

Takeaway

This study shows that certain cancer drugs need to be changed into a different form to be moved out of cells, and a specific protein helps with that process.

Methodology

The study used membrane vesicles from cells expressing recombinant MRP1 to measure the transport rates of various glutathione S-conjugates.

Limitations

The study does not address the full range of factors influencing drug resistance beyond MRP1 activity.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication